Ovation Science Inc
Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in the United States. The company's patented skin delivery technology Invisicare, a patented polymer-based technology for topical and transdermal skin care products under the Ovation brand name. It also offers cannabis health and wellness solutions under the Invibe MD name; anti-aging products and… Read more
Ovation Science Inc (OVATF) - Total Liabilities
Latest total liabilities as of September 2025: $1.45 Million USD
Based on the latest financial reports, Ovation Science Inc (OVATF) has total liabilities worth $1.45 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Ovation Science Inc - Total Liabilities Trend (2017–2024)
This chart illustrates how Ovation Science Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Ovation Science Inc Competitors by Total Liabilities
The table below lists competitors of Ovation Science Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hiremii Ltd
AU:HMI
|
Australia | AU$4.74 Million |
|
CONSOLIDATED EDISON - Dusseldorf Stock Exchang
DU:EDC
|
Germany | €46.75 Billion |
|
Fanhua Inc.
NASDAQ:AIFU
|
USA | $1.16 Billion |
|
Lifeist Wellness Inc.
OTCQB:LFSWF
|
USA | $708.54K |
|
PACCAR (PAE.SG)
STU:PAE
|
Germany | €24.62 Billion |
|
Sawang Export Public Company Limited
BK:SAWANG
|
Thailand | ฿29.78 Million |
|
Infield Minerals Corp
V:INFD
|
Canada | CA$195.42K |
Liability Composition Analysis (2017–2024)
This chart breaks down Ovation Science Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.02 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 50.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Ovation Science Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Ovation Science Inc (2017–2024)
The table below shows the annual total liabilities of Ovation Science Inc from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $1.15 Million | +58.34% |
| 2023-12-31 | $728.99K | +288.10% |
| 2022-12-31 | $187.84K | +194.69% |
| 2021-12-31 | $63.74K | -55.54% |
| 2020-12-31 | $143.38K | -60.42% |
| 2019-12-31 | $362.24K | -32.40% |
| 2018-12-31 | $535.84K | +60.48% |
| 2017-12-31 | $333.91K | -- |